Aptamers as new promising entities for therapeutics:our experience from the neurological diseases
Macarena Hernández-Jiménez1
Fernando de Castro2
1.Neurovascular Research Unit,Pharmacology and Toxicology Department,Complutense University,Madrid,Spain;AptaTargets S.L.,Avda.Cardenal Herrera Oria,Madrid,Spain;Instituto de Investigación Hospital 12 de Octubre,Madrid,Spain2.Instituto Cajal-CSIC,Madrid,Spain
摘要：Based on data from Global Burden of Disease,Injuries,and Risk Factors(2024),disorders of the central nervous system(CNS)are an important cause of death or long-term disability,representing the top-ranked contributor to global disability adjusted life years.
机标关键词：aptamersfromdiseasesentitiesexperienceneurologicalpromisingtherapeutics
论文发表日期：2025-12-27
在线出版日期：2025-08-15（本平台首次上网日期，不代表文献的发表时间）
页数：2( 3523-3524 )